Crescendo Bioscience, Inc.
South San Francisco, CA, US· latest recorded location
CRESCENDO BIOSCIENCE, INC. is named on 4 US grants and 16 published applications in this corpus. Its most frequent classification is G01N (Investigating or analysing materials by determining their chemical or physical properties).
- Granted patents
- 4
- Published applications
- 16
- Inventors
- 16
- Granted in 2026 so far
- 0
- Most recent grant
- 20 Apr 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 4 |
| 2018 | 0 | 2 |
| 2019 | 0 | 1 |
| 2020 | 1 | 3 |
| 2021 | 2 | 2 |
| 2022 | 0 | 1 |
By publication year.
Technology areas
Share of 20 documents
- G01NInvestigating or analysing materials by determining their chemical or physical properties20
- G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or17
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms11
- G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the7
- A61PTherapeutic uses of medicines6
- C07KPeptides3
- G09BEducational or demonstration appliances3
Recent patents
- Methods for assessing response to inflammatory disease therapy withdrawal20 Apr 2021US 10,983,120 B2
- Biomarkers and methods for assessing myocardial infarction and serious infection risk in rheumatoid arthritis patients30 Mar 2021US 10,962,552 B2
- Biomarkers and methods for measuring and monitoring juvenile idiopathic arthritis activity21 Jul 2020US 10,718,765 B2
- Biomarkers and methods for measuring and monitoring inflammatory disease activity1 Dec 2015US 9,200,324 B2
- Biomarkers and methods for assessing psoriatic arthritis disease activity7 Jul 2022US 2022/0214341 A1
- Biomarkers and methods for assessing response to inflammatory disease therapy withdrawal8 Jul 2021US 2021/0208139 A1
- Biomarkers and methods for assessing myocardial infarction and serious infection risk in rheumatoid arthritis patients1 Jul 2021US 2021/0199671 A1
- Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity24 Dec 2020US 2020/0400682 A1
- Biomarkers and methods for measuring and monitoring juvenile idiopathic arthritis activity24 Sep 2020US 2020/0300853 A1
Most cited
By later US patents
- Biomarkers and methods for measuring and monitoring inflammatory disease activity16US 9,200,324 B22015
- Biomarkers and methods for measuring and monitoring juvenile idiopathic arthritis activity7US 10,718,765 B22020
- Biomarkers and methods for assessing myocardial infarction and serious infection risk in rheumatoid arthritis patients1US 10,962,552 B22021